Abstract:Background and Aims Alcohol consumption is a well‐established risk factor for the onset and progression of hepatic steatosis. Perilipin 5 (Plin5), a lipid droplet protein, is an important protective factor against hepatic lipotoxicity induced by excessive lipolysis, but its role and molecular mechanism in alcoholic liver disease (ALD) are not fully elucidated. Methods The optimized National Institute on Alcohol Abuse and Alcoholism model was used to construct ALD model mice. Automatic biochemical analyser was used for Biochemical Parameters. The primary hepatocytes and Plin5‐overexpressed HepG2 cells (including full‐length Plin5 and Plin5 deleting 444–464 aa) were used for in vitro experiment. Haematoxylin and Eosin staining, Oil Red O staining, Bodipy 493/503 staining, Periodic Acid‐Schiff staining, immunohistochemistry and JC‐1 staining were used to evaluate cell morphology, lipids, glycogen, inflammation and membrane potential. Commercially kits are used to detect glycolipid metabolites, such as triglycerides, glycogen, glucose, reactive oxygen species, lactic acids, ketone bodies. Fluorescently labelled deoxyglucose, NBDG, was used for glucose intake. An XF96 extracellular flux analyser was used to determinate oxygen consumption rate in hepatocytes. The morphological and structural damage of mitochondria was evaluated by electron microscopy. Classical ultracentrifugation is used to separate the subcellular organelles of tissues and cells. Immunoblotting and qPCR were used to detect changes in mRNA and protein levels of related genes. Results Our results showed that the expression of Plin5 in mouse livers was enhanced by alcohol intake, and Plin5 deficiency aggravated the alcohol‐induced liver injury. To clarify the mechanism, we found that Plin5 deficiency significantly elevated the hepatic NADH levels and ketone body production in the alcohol‐treated mice. As NADH elevation could promote the reduction of pyruvate into lactate and then inhibit the gluconeogenesis, alcohol‐treated Plin5‐deficient mice exhibited more lactate production and severer hypoglycemia. These results implied that Plin5 deficiency impaired the mitochondrial oxidative functions in the presence of alcohol. In addition, we demonstrated that Plin5 could be recruited onto mitochondria by alcohol, while Plin5 without mitochondrial targeting sequences lost its mitochondrial protection functions. Conclusion Collectively, this study demonstrated that the mitochondrial Plin5 could protect the alcohol‐induced mitochondrial injury, which provides an important new insight on the roles of Plin5 in highly oxidative tissues.

Plin5, a New Target in Diabetic Cardiomyopathy

PLIN5 Suppresses Lipotoxicity and Ferroptosis in Cardiomyocyte via Modulating PIR/NF-κB Axis

Plin5 alleviates myocardial ischaemia/reperfusion injury by reducing oxidative stress through inhibiting the lipolysis of lipid droplets

Perilipin 5 deficiency aggravates cardiac hypertrophy by stimulating lactate production in leptin-deficient mice

Research and development of Lipin family

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Perilipin 5 Protects against Cellular Oxidative Stress by Enhancing Mitochondrial Function in HepG2 Cells

Lipin-1 Deficiency Deteriorates Defect of Fatty Acid Β-Oxidation and Lipid-Related Kidney Damage in Diabetic Kidney Disease.

PLIN5 interacts with FATP4 at membrane contact sites to promote lipid droplet-to-mitochondria fatty acid transport

Spatially resolved rewiring of mitochondria-lipid droplet interactions in hepatic lipid homeostasis.

Plin4-Dependent Lipid Droplets Hamper Neuronal Mitophagy in the MPTP/p-Induced Mouse Model of Parkinson’s Disease

Perilipin 5 protects the mitochondrial oxidative functions and improves the alcoholic liver injury in mice

Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease

Abstract 279: Increased Drp1 Acetylation Mediates Lipid Overload-induced Cardiomyocyte Death & Heart Dysfunction

Development of hypertrophic cardiomyopathy in perilipin-1 null mice with adipose tissue dysfunction.

Disruption of Plin5 degradation by CMA causes lipid homeostasis imbalance in NAFLD

The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy

Perilipin 5 deletion protects against nonalcoholic fatty liver disease and hepatocellular carcinoma by modulating lipid metabolism and inflammatory responses

Perilipin 5 S155 phosphorylation by PKA is required for the control of hepatic lipid metabolism and glycemic control

Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy

Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies